test

Ron Rosenstraus

@Eversept Partners, Lp

Latest period2024 - Q3ReportedManaged Assets$1.46BTotal holdings67
Assets growth rate-0.03%Assets growth rate (2-Q avg)-1.3%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Eversept Partners, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 67 positions.

Assets under management

The assets under management (AUM) of Eversept Partners, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.46B in assets, with a quarterly growth rate of -0.03% and a 2-quarter average growth rate of -1.3%. The portfolio is managed by Ron Rosenstraus, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
TECHBio-techne Corp
Recent Activity
Increased 22.2%
3.64%
$53.039M
663,573 shares@ $79.94 avg price
HCAHca Healthcare Inc
Recent Activity
Decreased -4.72%
3.6%
$52.464M
129,084 shares@ $406.43 avg price
UTHRUnited Therapeutics Corp Del
Recent Activity
Decreased -44.36%
3.22%
$46.926M
130,949 shares@ $358.35 avg price
SPYSpdr S&p 500 Etf Tr
Recent Activity
Increased 94.81%
2.36%
$34.426M↓ Put
60,000 shares@ $573.76 avg price
ZIMVZimvie Inc
Recent Activity
Increased 169.76%
2.26%
$32.863M
2.071M shares@ $15.88 avg price
HQYHealthequity Inc
Recent Activity
Decreased -22.84%
1.79%
$26.117M
319,078 shares@ $81.85 avg price
RGENRepligen Corp
Recent Activity
Decreased -15.8%
1.67%
$24.346M
163,593 shares@ $148.82 avg price
VTRSViatris Inc
Recent Activity
Increased 29.88%
1.38%
$20.043M
1.726M shares@ $11.62 avg price
PTGXProtagonist Therapeutics Inc
Recent Activity
Decreased -11.98%
1.38%
$20.034M
445,204 shares@ $45.0 avg price
CLDXCelldex Therapeutics Inc New
Recent Activity
Decreased -10.76%
1.32%
$19.201M
564,902 shares@ $34.0 avg price